We are live on ! Find out more
T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $145B
1-Year Est. Return 22.78%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+22.78%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
-$5.16B
Cap. Flow
-$7.02B
Cap. Flow %
-4.43%
Top 10 Hldgs %
22.66%
Holding
961
New
80
Increased
260
Reduced
443
Closed
63

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.18B
2
HOLX
Hologic
HOLX
+$1.14B
3
CI icon
Cigna
CI
+$1.05B
4
ROP icon
Roper Technologies
ROP
+$918M
5
DTE icon
DTE Energy
DTE
+$834M

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Healthcare 20.04%
3 Consumer Discretionary 13.58%
4 Financials 12.54%
5 Industrials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBF icon
276
PBF Energy
PBF
$8.69B
$84.3M 0.05%
3,108,975
-3,207,162
-51% -$103M
ATMU icon
277
Atmus Filtration Technologies
ATMU
$4.05B
$84.2M 0.05%
1,622,786
+297,851
+22% +$14.4M
PEB icon
278
Pebblebrook Hotel Trust
PEB
$2.04B
$82.7M 0.05%
7,303,706
-2,641,430
-27% -$29.1M
HE icon
279
Hawaiian Electric Industries
HE
$2.05B
$82.4M 0.05%
6,696,902
-5,582,746
-45% -$64.7M
TWFG
280
TWFG Inc
TWFG
$1.45B
$81.9M 0.05%
2,847,719
+26,742
+0.9% +$727K
CSTM icon
281
Constellium
CSTM
$3.96B
$81.7M 0.05%
4,334,727
-781,953
-15% -$13M
PRAX icon
282
Praxis Precision Medicines
PRAX
$10.5B
$81.5M 0.05%
+276,392
New +$51.5M
KNF icon
283
Knife River
KNF
$3.79B
$81.5M 0.05%
1,157,815
-13,745
-1% -$965K
CSW
284
CSW Industrials
CSW
$5.65B
$81.4M 0.05%
277,351
+105,350
+61% +$28.1M
RLI icon
285
RLI Corp
RLI
$5.82B
$80.9M 0.05%
1,264,642
-221,683
-15% -$13.9M
FIGS icon
286
FIGS
FIGS
$2.43B
$80.4M 0.05%
7,077,395
-2,490,430
-26% -$23.3M
IIIV icon
287
i3 Verticals
IIIV
$317M
$79.2M 0.05%
3,144,580
-8,831
-0.3% -$249K
STVN icon
288
Stevanato
STVN
$5.83B
$78.9M 0.05%
3,923,632
+368,792
+10% +$8.57M
SWX icon
289
Southwest Gas
SWX
$6.68B
$77.5M 0.05%
968,353
-519,887
-35% -$41.6M
BOOT icon
290
Boot Barn
BOOT
$4.98B
$76.7M 0.05%
434,352
-23,206
-5% -$4.33M
UFPI icon
291
UFP Industries
UFPI
$5.04B
$76.3M 0.05%
838,391
-132,176
-14% -$12.1M
WGS icon
292
GeneDx Holdings
WGS
$2.36B
$76M 0.05%
584,150
-133,853
-19% -$18.4M
JPM icon
293
JPMorgan Chase
JPM
$965B
$75.6M 0.05%
234,649
-2,098
-0.9% -$650K
HAE icon
294
Haemonetics
HAE
$4.12B
$75.6M 0.05%
943,185
-67,772
-7% -$4.55M
FND icon
295
Floor & Decor
FND
$6.3B
$74.4M 0.05%
1,222,487
+2,210
+0.2% +$143K
POST icon
296
Post Holdings
POST
$3.67B
$74.2M 0.05%
749,156
-509,529
-40% -$52.7M
BRKRP
297
Bruker Corporation 6.375% Series A Preferred Stock
BRKRP
$1.2B
0
WK icon
298
Workiva
WK
$3.71B
$72.6M 0.05%
842,025
-752,416
-47% -$66.6M
IBOC icon
299
International Bancshares
IBOC
$4.54B
$72.5M 0.05%
1,091,549
+70,193
+7% +$4.75M
FSBC icon
300
Five Star Bancorp
FSBC
$1.16B
$72.2M 0.05%
2,017,380
+18,668
+0.9% +$647K

Similar funds

T. Rowe Price Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, T. Rowe Price Investment Management held 961 positions worth $158B, down 3.2% from $164B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

T. Rowe Price Investment Management withdrew a net $7.02B in Q4 2025, closing 63 positions and reducing 443 holdings. Its most notable exit was Bright Horizons, an estimated $240M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Investment Management opened a new position in Keurig Dr Pepper worth $728M.

  • T. Rowe Price Investment Management's largest Q4 2025 buy was Keurig Dr Pepper: 25,978,817 shares worth $728M.
  • T. Rowe Price Investment Management added most to Cencora in Q4 2025, an estimated $1.41B increase.
  • T. Rowe Price Investment Management's biggest Q4 2025 reduction was Danaher, cutting an estimated $1.18B.
  • T. Rowe Price Investment Management fully exited Bright Horizons in Q4 2025, selling an estimated $240M.
  • T. Rowe Price Investment Management's ten largest holdings make up 23% of its $158B portfolio in Q4 2025.
  • T. Rowe Price Investment Management opened 80 new positions and closed 63 in Q4 2025.
  • T. Rowe Price Investment Management's portfolio value fell 3.2% quarter-over-quarter to $158B.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.